Clinical Ultrasound Transducer Research Articles

High-Volume-Rate 3-D Ultrasound Imaging Using Fast-Tilting and Redirecting Reflectors.

Three-dimensional ultrasound imaging has many advantages over 2-D imaging such as more comprehensive tissue evaluation and less operator dependence. However, developing a low-cost and accessible 3-D ultrasound solution with high volume rate and imaging quality remains a challenging task. Recently, we proposed a 3-D ultrasound imaging technique: fast acoustic steering via tilting electromechanical reflectors (FASTER), which uses a fast-tilting acoustic reflector to steer ultrafast plane waves elevationally to achieve high-volume-rate 3-D imaging with conventional 1-D transducers. However, the initial FASTER implementation requires a water tank for acoustic wave conduction and cannot be conveniently used for regular handheld scanning. To address these limitations, here, we developed a novel ultrasound probe clip-on device that encloses a fast-tilting reflector, a redirecting reflector, and an acoustic wave conduction medium. The new FASTER 3-D imaging device can be easily attached to or removed from clinical ultrasound transducers, allowing rapid transformation from 2-D to 3-D imaging. In vitro B-mode studies demonstrated that the proposed method provided comparable imaging quality to conventional, mechanical-translation-based 3-D imaging while offering a much faster volume rate (e.g., 300 versus ∼ 10 Hz). We also demonstrated 3-D power Doppler (PD) and 3-D super-resolution ultrasound localization microscopy (ULM) with the FASTER device. An in vivo imaging study showed that the FASTER device could clearly visualize the 3-D anatomy of the basilic vein. These results suggest that the newly developed redirecting reflector and the clip-on device could overcome key hurdles for future clinical translation of the FASTER 3-D imaging technology.

Plug and Pop: A 3D-Printed, Modular Platform for Drug Delivery Using Clinical Ultrasound and Microbubbles.

Targeted drug and gene delivery using ultrasound and microbubbles (USMB) has the potential to treat several diseases. In vitro investigation of USMB-mediated delivery is of prime importance prior to in vivo studies because it is cost-efficient and allows for the rapid optimization of experimental parameters. Most in vitro USMB studies are carried out with non-clinical, research-grade ultrasound systems, which are not approved for clinical use and are difficult to replicate by other labs. A standardized, low-cost, and easy-to-use in vitro experimental setup using a clinical ultrasound system would facilitate the eventual translation of the technology to the bedside. In this paper, we report a modular 3D-printed experimental setup using a clinical ultrasound transducer that can be used to study USMB-mediated drug delivery. We demonstrate its utility for optimizing various cargo delivery parameters in the HEK293 cell line, as well as for the CMT167 lung carcinoma cell line, using dextran as a model drug. We found that the proportion of dextran-positive cells increases with increasing mechanical index and ultrasound treatment time and decreases with increasing pulse interval (PI). We also observed that dextran delivery is most efficient for a narrow range of microbubble concentrations.

Five-year evaluation of a low-cost quality assurance protocol for clinical ultrasound transducers.

To implement, execute and evaluate a quality assurance test protocol for clinical ultrasound transducers that is software-based, user-independent, inexpensive, easily repeatable, and does not require tissue phantoms. The test protocol is based on in-air reverberation images. The software test tool generates uniformity- and reverberation profiles to monitor system sensitivities and signal uniformities that provide a sensitive analysis of transducer status. Whenever a transducer was suspected to be damaged validating tests were conducted using the Sonora FirstCall test system. A total of 21 transducers from five ultrasound scanner systems were included in the study. Tests were performed every other month for a total of 5 years. Each transducer was tested on average 11.7 times. Testing a transducer required a total of 2.75 hours annually. The ultrasound quality assurance test protocol detected an average annual fail rate of 10.7%. The test protocol provides a reliable approach for monitoring transducer lens status of clinically used ultrasound transducers. The ultrasound quality assurance test protocol may potentially find deviations in diagnostic quality before being noticed by the clinicians. Thus, the ultrasound quality assurance test protocol holds the ability to reduce the risk of undiscovered image quality degradation hereby minimizing the danger of diagnostic errors.

Fetal Heart Rate Monitoring Implemented by Dynamic Adaptation of Transmission Power of a Flexible Ultrasound Transducer Array.

Fetal heart rate (fHR) monitoring using Doppler Ultrasound (US) is a standard method to assess fetal health before and during labor. Typically, an US transducer is positioned on the maternal abdomen and directed towards the fetal heart. Due to fetal movement or displacement of the transducer, the relative fetal heart location (fHL) with respect to the US transducer can change, leading to frequent periods of signal loss. Consequently, frequent repositioning of the US transducer is required, which is a cumbersome task affecting clinical workflow. In this research, a new flexible US transducer array is proposed which allows for measuring the fHR independently of the fHL. In addition, a method for dynamic adaptation of the transmission power of this array is introduced with the aim of reducing the total acoustic dose transmitted to the fetus and the associated power consumption, which is an important requirement for application in an ambulatory setting. The method is evaluated using an in-vitro setup of a beating chicken heart. We demonstrate that the signal quality of the Doppler signal acquired with the proposed method is comparable to that of a standard, clinical US transducer. At the same time, our transducer array is able to measure the fHR for varying fHL while only using 50% of the total transmission power of standard, clinical US transducers.

3D Ultrasound Imaging of Residual Limbs With Camera-Based Motion Compensation.

Ultrasound is a cost-effective, readily available, and non-ionizing modality for musculoskeletal imaging. Though some research groups have pursued methods that involve submerging the transducer and imaged body segment into a water bath, many limitations remain in regards to acquiring an unloaded volumetric image of an entire human limb in a fast, safe, and adequately accurate manner. A 3D dataset of a limb is useful in several rehabilitative applications including biomechanical modeling of soft tissue, prosthetic socket design, monitoring muscle condition and disease progression, bone health, and orthopedic surgery. This paper builds on previous work from our group and presents the design, prototyping, and preliminary testing of a novel multi-modal imaging system for rapidly acquiring volumetric ultrasound imagery of human limbs, with a particular focus on residual limbs for improved prosthesis design. Our system employs a mechanized water tank setup to scan a limb with a clinical ultrasound transducer and 3D optical imagery to track motion during a scan. The iterative closest point algorithm is utilized to compensate for motion and stitch the images into a final dataset. The results show preliminary 2D and 3D imaging of both a tissue-mimicking phantom and residual limbs. A volumetric error compares the ultrasound image data obtained to a previous MRI method. The results indicate potential for future clinical implementation. Concepts presented in this paper could reasonably transfer to other imaging applications such as acoustic tomography, where motion artifact may distort image reconstruction.

Signed Real-Time Delay Multiply and Sum Beamforming for Multispectral Photoacoustic Imaging

Reconstruction of photoacoustic (PA) images acquired with clinical ultrasound transducers is usually performed using the Delay and Sum (DAS) beamforming algorithm. Recently, a variant of DAS, referred to as Delay Multiply and Sum (DMAS) beamforming has been shown to provide increased contrast, signal-to-noise ratio (SNR) and resolution in PA imaging. The main reasons for the use of DAS beamforming in photoacoustics are its simple implementation, real-time capability, and the linearity of the beamformed image to the PA signal. This is crucial for the identification of different chromophores in multispectral PA applications. In contrast, current DMAS implementations are not responsive to the full spectrum of sound frequencies from a photoacoustic source and have not been shown to provide a reconstruction linear to the PA signal. Furthermore, due to its increased computational complexity, DMAS has not been shown yet to work in real-time. Here, we present an open-source real-time variant of the DMAS algorithm, signed DMAS (sDMAS), that ensures linearity in the original PA signal response while providing the increased image quality of DMAS. We show the applicability of sDMAS for multispectral PA applications, in vitro and in vivo. The sDMAS and reference DAS algorithms were integrated in the open-source Medical Imaging Interaction Toolkit (MITK) and are available as real-time capable implementations.

Processing methods for photoacoustic Doppler flowmetry with a clinical ultrasound scanner.

Photoacoustic flowmetry (PAF) based on time-domain cross correlation of photoacoustic signals is a promising technique for deep tissue measurement of blood flow velocity. Signal processing has previously been developed for single element transducers. Here, the processing methods for acoustic resolution PAF using a clinical ultrasound transducer array are developed and validated using a 64-element transducer array with a -6 dB detection band of 11 to 17MHz. Measurements were performed on a flow phantom consisting of a tube (580 μm inner diameter) perfused with human blood flowing at physiological speeds ranging from 3 to 25 mm / s. The processing pipeline comprised: image reconstruction, filtering, displacement detection, and masking. High-pass filtering and background subtraction were found to be key preprocessing steps to enable accurate flow velocity estimates, which were calculated using a cross-correlation based method. In addition, the regions of interest in the calculated velocity maps were defined using a masking approach based on the amplitude of the cross-correlation functions. These developments enabled blood flow measurements using a transducer array, bringing PAF one step closer to clinical applicability.

Phantom-based image quality test methods for photoacoustic imaging systems.

As photoacoustic imaging (PAI) technologies advance and applications arise, there is increasing need for standardized approaches to provide objective, quantitative performance assessment at various stages of the product development and clinical translation process. We have developed a set of performance test methods for PAI systems based on breast-mimicking tissue phantoms containing embedded inclusions. Performance standards for mature imaging modalities [magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound] were used to guide selection of critical PAI image quality characteristics and experimental methods. Specifically, the tests were designed to address axial, lateral, and elevational spatial resolution, signal uniformity, penetration depth, sensitivity, spatial measurement accuracy, and PAI-ultrasound coregistration. As an initial demonstration of the utility of these test methods, we characterized the performance of a modular, bimodal PAI-ultrasound system using four clinical ultrasound transducers with varying design specifications. Results helped to inform optimization of acquisition and data processing procedures while providing quantitative elucidation of transducer-dependent differences in image quality. Comparison of solid, tissue-mimicking polymer phantoms with those based on Intralipid indicated the superiority of the former approach in simulating real-world conditions for PAI. This work provides a critical foundation for the establishment of well-validated test methods that will facilitate the maturation of PAI as a medical imaging technology.

SU-E-I-114: Clinical Ultrasound Transducer Degradation Effects on the Accuracy of Spectral Doppler Velocity Measurements.

Ultrasound Doppler velocity measurements are routinely used to determine the severity of a stenosis in the carotid, renal or peripheral arteries. The objective of this study is to investigate and demonstrate the relationship between Doppler velocity measurements and transducer degradation conditions encountered in a clinical environment. Assessing transducer performance was accomplished using the First Call aPerio Test System transducer analyzer (Sonora Medical Systems, Longmont, CO). This system was used to conduct 1,145 semi-annual transducer assessments at 7 clinical sites from September 2007 to February 2012 as part of a comprehensive quality control program. The results were evaluated to determine the degree of transducer degradation encountered in the clinical environment. A Siemens Acuson S2000 (Siemens AG, Erlangen, Germany) ultrasound system was employed with the 1425A LE Doppler Flow System (Gammex, Middleton, WI) to determine Doppler velocity measurements. A transducer fixation device was fabricated to provide accurate, repeatable velocity measurements. Transducers with the most severe degradation were evaluated by comparing velocity measurements to those without defects. Using several matched transducer pairs, simulated failure modes were tested. The Doppler measured time-average mean (TAMn) and time-average maximum (TAMx) velocities were obtained and reported. This investigation found that 4.5% of the transducers surveyed during this 5-year period of time failed at least one acceptance criteria. Many (346 or 30%) had at least one defect. Typical findings include dead elements, lens delamination, wire cuts, and capacitance shorts. Only the most severe transducer defects and degradation conditions resulted in a noticeable deviation in the velocity measurements. Simulated transducer degradation testing confirmed this finding. The relationship between Doppler velocity measurements and transducer degradation conditions is limited, becoming significant for only the most severe degradation conditions. Based on our experience, this level of transducer degradation is rarely encountered in the clinical environment.

Optical Microscopic Findings of the Behavior of Perflubutane Microbubbles Outside and Inside Kupffer Cells During Diagnostic Ultrasound Examination

To investigate the behavior of perflubutane microbubbles outside and inside Kupffer cells during diagnostic ultrasound (US) examination, and to determine the thresholds of the acoustic pressure of different kinds of behavior. Acoustic behavior of perflubutane microbubbles inside and outside Kupffer cells in an acoustic field induced by a clinical US transducer and equipment was optically observed in vitro. The acoustic pressure was measured simultaneously by a calibrated hydrophone and an oscilloscope. The acoustic behavior of microbubbles was optically categorized as stabilization, oscillation, transposition, shrinkage, and destruction. The mechanical index (MI) displayed on the US equipment correlated well with the acoustic pressure at the level of microbubbles measured hydrophonically. At a frame rate of 15 Hz with a frequency of 3.5 MHz and pulse repetition frequency of 3 KHz, the thresholds in term of MI for free microbubbles to begin oscillation, reach best oscillation, transposition, shrinkage, and destruction were 0.21, 0.44, 0.53, 0.75, and 1.03, respectively. Although adherent and phagocytosed microbubbles showed more stability enduring insonation compared with free microbubbles, the thresholds of shrinkage and destruction were MI 1.03 and 1.18 for adherent microbubbles, and 1.18 and 1.37 for phagocytosed microbubbles, respectively. Neither oscillation nor transposition of microbubbles inside Kupffer cells was observed microscopically. No cell damage because of microbubbles destruction was found in the present study. Perflubutane microbubbles outside and inside Kupffer cells respond to external US insonation with same parameters of a clinical contrast-enhanced US study according to the acoustic pressure. Free microbubbles behave as stabilization, oscillation, transposition, shrinkage, and destruction under insonation. The adherent and phagocytosed microbubbles are more stable under insonation than free microbubbles, but still respond showing shrinkage and destruction when MI is over 1.03.

Prediction of the Temperature Rise at the Surface of Clinical Ultrasound Transducers

Prediction of the Temperature Rise at the Surface of Clinical Ultrasound Transducers

Focused transducer beams in tissue-mimicking material.

AbstractA comparison is made between pulse echo response profiles obtained in water and profiles obtained in a tissue‐mimicking (TM) material for clinical ultrasound transducers. The TM material is assumed to provide a more accurate indication of actual beam profiles in soft tissue because of the presence of frequency‐dependent attenuation in the material. Pulse echo response profiles measured in the TM medium demonstrate a reduction in the focal distance and degraded resolution distal to the focal distance, in comparison to profiles obtained in water.